FDA Inspection
Mylan Laboratories Limited (FDF-2)Mylan Laboratories Limited (FDF-2) – FDA Inspection, May 16, 2014
Record Details
This FDA Inspection record concerns Mylan Laboratories Limited (FDF-2), with an inspection on May 16, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- May 16, 2014
- Product Type
- Drugs
View Company Profile
ID · 53ebc2c6-eeb9-4b2d-8a99-ac4237992fe3
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 884211
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Mylan Laboratories Limited (FDF-2)
5| Date | Classification | Office | Project area |
|---|---|---|---|
| February 3, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 28, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 26, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 26, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 9, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Mylan Laboratories Limited (FDF-2)
- FDA Inspection 1253435 - 2023-02-03
- FDA Inspection 1122884 - 2020-02-28
- FDA Inspection 1091217 - 2019-04-26
- FDA Inspection 1012796 - 2017-05-26
- FDA Inspection 775616 - 2012-03-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.